J. Mysliwietz et S. Thierfelder, LONG-LASTING UNRESPONSIVENESS TO POLYCLONAL T-CELL-BINDING IMMUNOGLOBULINS, European Journal of Immunology, 28(1), 1998, pp. 246-256
We have shown that mice after a single injection of anti-T cell antibo
dy followed by multiple injections of a second xeno-, allo-or syngenei
c anti-T cell antibody differing from the former in species origin dev
eloped specific, long-lasting tolerance to the second antibody. To cha
racterize the mechanism of this anti-antibody unresponsiveness and the
modalities accompanying the preinjection step, we injected mice with
anti-pan T, anti-CD4 or anti-CD8 monoclonal antibodies, followed by mu
ltiple injections of polyclonal rabbit anti-mouse thymocyte globulin (
RbATG). Our observations indicate that: (i) Depletion of CD4(+) cells
is the most important factor for tolerance induction to subsequently i
njected RbATG. Non-depleting mAb were less effective, and antibody-ind
uced CD4 modulation or blockade were inconsequential. (ii) The prevent
ion of anti-antibody responses involves specific B cell tolerance, as
shown by suppression of anti-RbATG but not anti-bovine serum albumin (
BSA) antibodies after challenge of tolerant mice with RbATG-BSA conjug
ates. (iii) Suppression of anti-antibody responses involves T cell unr
esponsiveness rather marginally, as demonstrated by in vitro spleen ce
ll restimulation with RbATG and in vivo antibody response to RbATG-flu
orescein isothiocyanate hapten conjugate. (iv) Analysis of isotypes of
anti-RbATG antibodies does not suggest alterations in Th1/Th2 tuning
as being responsible for this kind of tolerance. (v) Over 150-day surv
ival of fully allogeneic skin grafts (CBA-to-C57BL/6) was observed in
mice preinjected with anti pan-T or anti-CD4 mAb followed by RbATG. Mi
ce treated with anti-CD4 mAb alone rejected allografts within 21 days
and induced anti-antibodies. Taken together, our experiments suggest B
cell tolerance as main mechanism in this type of acquired long-term h
umoral unresponsiveness to foreign, polyclonal, T cell-binding immunog
lobulins.